Crawford hold lifted
This article was originally published in The Gray Sheet
Executive Summary
Democratic Sens. Hillary Clinton (D-N.Y.) and Patty Murray (D-Wash.) remove their hold on the nomination of FDA Acting Commissioner Lester Crawford to the permanent post on news that FDA will issue a decision on switching thePlan B emergency contraceptive to over-the-counter use by Sept. 1. Sen. Tom Coburn (R-Okla.) also has removed his hold related to condom labeling regulations, according to his office (1"The Gray Sheet" June 20, 2005, p. 11)...
You may also be interested in...
FDA Commish Nominee Crawford Placed On Hold After Clearing Panel
Senate confirmation of FDA Commissioner-designee Lester Crawford continues to prove a complicated matter, despite the Health Committee's June 15 approval
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.